Keywords: هپارناز; Heparanase; Tissue factor; Heparins; TFPI-2 peptides;
مقالات ISI هپارناز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: هپارناز; ECM; extracellular matrix; ERK; extracellular signal-related kinase; HPSE; heparanase; MMP; matrix metalloproteinase; RANKL; receptor activator of nuclear factor-B ligand; TAM; tumor associated macrophage; TNF-α; tumor necrosis factor alpha; Chemoexosome
Keywords: هپارناز; Heparanase; Pancreatic neoplasm; Mononuclear cell; Metastasis; Survival;
Keywords: هپارناز; Echocardiography; Heparanase; Prosthetic valve thrombosis; Thromboembolism; Unfractionated heparin;
Keywords: هپارناز; Heparanase; Cartilage; Osteoarthritis; FGF2; MMP13;
Keywords: هپارناز; ADAMs; a disintegrin and metalloproteinases; ADAMTS; ADAMs with thrombospondin motifs; Col; collagen; CS; chondroitin sulfate; CTGF; connective tissue growth factor; DS; dermatan sulfate; ECM; extracellular matrix; EGF; epidermal growth factor; EMT; epith
Keywords: هپارناز; Heparanase; Bovine placenta; Syndecan; Gestation; Retention of fetal membranes;
Keywords: هپارناز; Heparanase; Diabetic foot; Amputation; Necrosis
Keywords: هپارناز; Heparanase; GPIHBP1; VEGF; Diabetic cardiomyopathy; STZ diabetes;
Keywords: هپارناز; Heparan sulfate proteoglycan; Heparanase; Heparanase inhibitor; Heparan sulfate mimetic; Sarcoma;
Keywords: هپارناز; Heparanase; Heparan sulfate; Inhibitors; Anti-Cancer agents;
Keywords: هپارناز; Heparanase; Chemotherapy; Multiple myeloma; Proteasome inhibitors; NF-κB; Roneparstat; HPSE; heparanase; (NF-κB); nuclear factor-kappa B; SDC1; syndecan-1; BTZ; bortezomib; CFZ; carfilzomib; HGF; hepatocyte growth factor; VEGF; vascular endothelial grow
Keywords: هپارناز; Heparanase; Tumorigenesis; Inflammation; Exosomes; Autophagy; Heparanase-inhibiting compounds; Chemoresistance; Clinical trials;
Keywords: هپارناز; Heparin; Heparan sulfate; Hyaluronan; Heparanase; Heparitinase;
Keywords: هپارناز; Low molecular weight heparin; Heparanase; Nanoliposome; Targeting; Lymph node metastasis;
Keywords: هپارناز; Lung cancer; Heparanase; Coagulation; Prognosis;
Keywords: هپارناز; Preeclampsia; Heparan sulfate; Dermatan sulfate; Hyaluronic acid; Heparanase
Keywords: هپارناز; Heparan sulfate proteoglycans; HSPGs; Heparan sulfate; HS; Endothelial cells; ECs; Glycosaminoglycans; GAGs; Extracellular matrix; ECM; Human aortic endothelial cells; HAECs; Calcium and magnesium-free Dulbecco's phosphate-buffered saline; CMF-DPBS; Thres
Keywords: هپارناز; Heparanase; Heparanase inhibitors; Drug target; Antitumor therapy
Keywords: هپارناز; Heparanase; Adenocarcinoma; Squamous cell carcinoma; Large cell carcinoma; Small cell carcinoma;
Keywords: هپارناز; heparin; heparan sulfate; metastasis; sulfyltransferase; sulfatase; heparanase
Keywords: هپارناز; Avascular necrosis; Heparanase; TFPI;
Keywords: هپارناز; Perlecan; Stellate reticulum; Enamel organ; Heparanase; Heparan sulfate;
Keywords: هپارناز; Heparanase; Heparan sulfate; Leukocyte migration; Basement membrane; Type 1 diabetes; Gene transcription;
Keywords: هپارناز; Heparan sulfate; Heparanase; Extracellular matrix; Tumor microenvironment; Macrophages; Inflammation; Cancer;
Keywords: هپارناز; Heparanase; Atherosclerosis; Heparan sulfate proteoglycans; Extracellular matrix; Smooth muscle cell; Inflammation;
The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway
Keywords: هپارناز; Diabetic nephropathy; The receptor for advanced glycation endproducts; Podocyte; Heparanase;
Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS
Keywords: هپارناز; Acute respiratory distress syndrome; Berberine; Endothelial glycocalyx; Matrix metalloproteinase 9; Heparanase; Lipopolysaccharide;
Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis
Keywords: هپارناز; Heparanase; Mammary gland; Development; Signaling; Tumorigenesis;
Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E0 mice
Keywords: هپارناز; Heparanase; PG545; Atherosclerosis; Oxidative stress; E0 mice;
Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases
Keywords: هپارناز; Heparanase; ssLMWH; Heparan sulfate mimetic; Synovial sarcoma; IGF1-Receptor; BMS754807;
Original ArticleExtracellular matrix alterations in the Peyronie's disease
Keywords: هپارناز; Peyronie; TGF-β; Interleukin-6; Glycosaminoglycans; Heparanase; Chondroitin sulfate; Metalloproteinases;
Heparanase-driven inflammation from the AGEs-stimulated macrophages changes the functions of glomerular endothelial cells
Keywords: هپارناز; Heparanase; Advanced glycation end products; Inflammatory factor; Permeability; Glomerular endothelial cell;
Low molecular weight fucoidan and its fractions inhibit renal epithelial mesenchymal transition induced by TGF-β1 or FGF-2
Keywords: هپارناز; LMWF; Low-molecular-weight fucoidan; F0.5; 0.5âM NaCl fraction; F1.0; 1.0âM NaCl fraction; EMT; Epithelial mesenchymal transition; TGF-β1; Transforming growth factor-β1; FGF-2; Fibroblast growth factor-2; HPSE; Heparanase; ECM; Extracellular matrix;
Production of heparin and λ-carrageenan anti-heparanase derivatives using a combination of physicochemical depolymerization and glycol splitting
Keywords: هپارناز; LMW; low molecular weight; HS; heparan sulfate; ECM; extracellular matrix; UF; unfractioned; RD; depolymerized with radical hydrolysis assisted by ultrasound; HexA; hexuronic acid; GS; glycol split; RD-GS; depolymerized then glycol splitted; GS-RD; glycol
Structural features of heparanase-inhibiting non-anticoagulant heparin derivative Roneparstat
Keywords: هپارناز; gs; glycol-split; LMWH; low-molecular weight heparin; U; uronic acid; I; l-iduronic acid; G; d-glucuronic acid; I2S; l-iduronic acid 2-O-sulfate; ANS6S; d-glucosamine-N,6-O-disulfate; ANAc; N-acetylated d-glucosamine; ANS3S6S; d-glucosamine N,3-O,6-O-tris
Heparanase augments inflammatory chemokine production from colorectal carcinoma cell lines
Keywords: هپارناز; Heparanase; Chemokine; Heparan sulfate; Colorectal carcinoma; BSA; bovine serum albumin; D/F medium; a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium; ELISA; enzyme-linked immunosorbent assay; FCS; fetal calf serum; HS; heparan sul
Astilbin alleviates LPS-induced ARDS by suppressing MAPK signaling pathway and protecting pulmonary endothelial glycocalyx
Keywords: هپارناز; Acute respiratory distress syndrome; Astilbin; Mitogen-activated protein kinase signaling pathways; Endothelial glycocalyx; Heparanase;
Anti-heparanase activity of ultra-low-molecular-weight heparin produced by physicochemical depolymerization
Keywords: هپارناز; Heparin; Ultrasonic-assisted radical hydrolysis; Heparinase I-catalyzed β-elimination; Glycol-split; Heparanase; Anti-angiogenesis;
Development of new methods for determining the heparanase enzymatic activity
Keywords: هپارناز; Heparanase; endo-Beta-glucuronidase; Recombinant heparanase; Chimeric heparanase; Enzymatic assay; Heparanase activity
Experimental evidence of heparanase, Hsp70 and NF-κB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation
Keywords: هپارناز; Intestinal inflammation; Heparanase; Hsp70; NF-κB; Inflammatory bowel disease; Intestinal anti-inflammatory drugs;
Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis
Keywords: هپارناز; HGF; Heparanase; Gastric cancer; PI3K/Akt; NF-κBHGF, hepatocyte growth factor; HPA, heparanase; HSPG, heparan sulfate chains of proteoglycans; VEGF, vascular endothelial growth factor; FGF, fibroblast growth factor; MMPs, matrix metalloproteinases; ECM, e
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples
Keywords: هپارناز; PG545; Ovarian cancer; Tumour microenvironment; Heparanase; VEGF; HB-EGF;
1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase
Keywords: هپارناز; Heparanase; Fondaparinux; Glycosidase mechanisms; NMR spectroscopy;
Implications of heparan sulfate and heparanase in neuroinflammation
Keywords: هپارناز; HS; heparan sulfate; HSPG; heparan sulfate proteoglycan; SDC; syndecan; GPC; glypican; -OST; -O-sulfotransferase; NDST; N-deacetylase-N-sulfotransferase; FGF; fibroblast growth factor; CNS; central nervous system; BBB; Blood Brain Barrier; ECM; extracel
3D QSAR based design of novel substituted urea molecules as heparanase inhibitors
Keywords: هپارناز; Heparanase; Three dimensional structure activity relationship (3D QSAR); Comparative molecular field analysis (CoMFA); Comparative molecular similarity indices (CoMSIA); 1,3-Bis[4-(1H-bezimidazol-2-yl)-phenyl urea;
Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease
Keywords: هپارناز; Multiple myeloma; Bone disease; Heparanase; Osteoblastogenesis; Adipogenesis; Bone microenvironment;
Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation
Keywords: هپارناز; Heparanase; Promoter; Methylation; Colon carcinoma
Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues
Keywords: هپارناز; Heparanase; PG545; Inhibitor; Kinetics; CancerECM, extracellular matrix; HS, heparan sulfate; HSPG, heparan sulfate proteoglycan; SE, standard error; SS, sum of squares; WST-1, 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate
A fluorescent spectroscopy and modelling analysis of anti-heparanase aptamers–serum protein interactions
Keywords: هپارناز; Modelling; Aptamers; Heparanase; Albumin; Quenching of fluorescence